Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
BL21 probiotic added to metformin in adults with type 2 diabetes.
Empagliflozin added to insulin therapy in adults with type 1 diabetes.
Early combination therapy with insulin degludec and intravenous insulin infusion in adults with diabetic ketoacidosis.
This study evaluated the impact of Continuous Positive Airway Pressure (CPAP) on visual acuity in individuals with type 2 diabetes and diabetic macular oedema. No significant differences were found in visual acuity between CPAP and usual care groups.
Gamified mHealth app (DiaSocial) for diabetes management in older veterans with poorly controlled Type 2 diabetes.
This study analyzed health-related quality of life (HRQoL) in dietary interventions for type 2 diabetes, finding improvements in both low-carbohydrate high-fat (LCHF) and high-carbohydrate low-fat (HCLF) diets.
Non-surgical periodontal treatment with topical antibiotics showed improvements in glycemic control among type 2 diabetes patients.
This study investigated the impact of ozone therapy on glycated hemoglobin levels in type 2 diabetes patients, finding no significant reduction in HbA1c levels.
This study evaluated the efficacy and safety of empagliflozin in adults with type 2 diabetes who were not adequately controlled on metformin and sitagliptin. Results indicated significant reductions in HbA1c and body weight with empagliflozin treatment.
This study evaluated the efficacy and hypoglycaemia outcomes of once-weekly insulin icodec compared to once-daily basal insulin in adults with type 2 diabetes.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
